Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|November 8, 2019
Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMTE Domingo-Domènech, A Boumendil, F Climent, et al.
Bone Marrow Transplantation|July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMTY Chalandon, J R Passweg, C Schmid, et al.
Annals of Hematology|September 22, 2016
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMTE M P Cremers, A van Biezen, L C de Wreede, et al.
Journal of Internal Medicine|October 14, 2017
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?O Ringdén, M Labopin, B Sadeghi, et al.
Leukemia|May 10, 2017
MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantationN Stickel, K Hanke, D Marschner, et al.
Leukemia|February 23, 2011
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemiaC Craddock, M Labopin, S Pillai, et al.
Leukemia|August 6, 2011
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphomaM Deckert, A Engert, W Brück, et al.
Bone Marrow Transplantation|December 8, 2015
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?M C Oliveira, M Labopin, J Henes, et al.
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Bone Marrow Transplantation|August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)A R Zander, N Kröger, M Schleuning, et al.
Pageof 22